The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer.
 
Sachin Babanrao Dhumal
No Relationships to Disclose
 
Vijay Maruti Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Vanita Noronha
Research Funding - Amgen (Inst); AstraZeneca (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Nandini Sharrel Menon
No Relationships to Disclose
 
Kavita Prakash Nawale
No Relationships to Disclose
 
Manoj Mahimkar
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); NATCO Pharma (Inst); Roche (Inst)